Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March ...

Stay up-to-date with the Dr Reddys Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

By Rishika Sadam and Kashish Tandon HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's, which reported a ...

Stay informed with the Dr Reddys Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

An analyst from Mirae Asset Sharekhan said that Waaree Energies has endured a sharp correction, reflecting sector rotation ...

The total revenue of the Hyderabad based company grew 4.4% at ₹8,726 crore against ₹8,358 crore in the same period last year ...

It’s critical to keep your workplace equipment clean and calibrated—especially in the realm of pharmaceutical manufacturing. Now, Dr. Reddy’s failure to uphold those standards has landed the Indian ...

Brokerages said Dr Reddy's Laboratories Q3 FY26 earnings beat was driven largely by the domestic and emerging markets portfolio, which helped offset weakness in the US.

HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) has been ranked among the top employers according to the 2024 Top Biotech and Pharma Employers Survey conducted by ...

Move comes even as pricing pressure and regulatory complexity continue to weigh on global pharmaceutical markets.